Hollsteen
← Cadence

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 2016: $180M · 10-Q 0000813672-16-000045 filed Apr 25, 2016Research and development · Q2 2016: $182M · 10-Q 0000813672-16-000050 filed Jul 25, 2016Research and development · Q3 2016: $192M · 10-Q 0000813672-16-000056 filed Oct 24, 2016Research and development · Q4 2016: $182M · derived · 10-K 0000813672-18-000008 filed Feb 20, 2018Research and development · Q1 2017: $198M · 10-Q 0000813672-17-000011 filed Apr 25, 2017Research and development · Q2 2017: $196M · 10-Q 0000813672-17-000017 filed Jul 24, 2017Research and development · Q3 2017: $207M · 10-Q 0000813672-17-000023 filed Oct 26, 2017Research and development · Q4 2017: $203M · derived · 10-K 0000813672-19-000008 filed Feb 27, 2019Research and development · Q1 2018: $224M · 10-Q 0000813672-18-000014 filed Apr 25, 2018Research and development · Q2 2018: $219M · 10-Q 0000813672-18-000020 filed Jul 23, 2018Research and development · Q3 2018: $223M · 10-Q 0000813672-18-000025 filed Oct 22, 2018Research and development · Q4 2018: $218M · derived · 10-K 0000813672-20-000007 filed Feb 24, 2020Research and development · Q1 2019: $228M · 10-Q 0000813672-19-000014 filed Apr 22, 2019Research and development · Q2 2019: $232M · 10-Q 0000813672-19-000022 filed Jul 22, 2019Research and development · Q3 2019: $241M · 10-Q 0000813672-19-000027 filed Oct 21, 2019Research and development · Q4 2019: $235M · derived · 10-K/A 0000813672-21-000021 filed May 14, 2021Research and development · Q1 2020: $242M · 10-Q 0000813672-20-000013 filed Apr 20, 2020Research and development · Q2 2020: $251M · 10-Q 0000813672-20-000020 filed Jul 20, 2020Research and development · Q3 2020: $251M · 10-Q 0000813672-20-000027 filed Oct 19, 2020Research and development · Q4 2020: $290M · derived · 10-K 0000813672-22-000012 filed Feb 22, 2022Research and development · Q1 2021: $271M · 10-Q 0000813672-21-000016 filed Apr 26, 2021Research and development · Q2 2021: $285M · 10-Q 0000813672-21-000028 filed Jul 26, 2021Research and development · Q3 2021: $289M · 10-Q 0000813672-21-000037 filed Oct 25, 2021Research and development · Q4 2021: $289M · derived · 10-K 0000813672-23-000011 filed Feb 13, 2023Research and development · Q1 2022: $291M · 10-Q 0000813672-22-000022 filed Apr 25, 2022Research and development · Q2 2022: $287M · 10-Q 0000813672-22-000037 filed Jul 25, 2022Research and development · Q3 2022: $324M · 10-Q 0000813672-22-000054 filed Oct 24, 2022Research and development · Q4 2022: $350M · derived · 10-K 0000813672-24-000034 filed Feb 14, 2024Research and development · Q1 2023: $350M · 10-Q 0000813672-23-000025 filed Apr 24, 2023Research and development · Q2 2023: $354M · 10-Q 0000813672-23-000041 filed Jul 24, 2023Research and development · Q3 2023: $370M · 10-Q 0000813672-23-000068 filed Oct 23, 2023Research and development · Q4 2023: $367M · derived · 10-K 0000813672-25-000024 filed Feb 21, 2025Research and development · Q1 2024: $379M · 10-Q 0000813672-24-000092 filed Apr 24, 2024Research and development · Q2 2024: $371M · 10-Q 0000813672-24-000155 filed Jul 24, 2024Research and development · Q3 2024: $407M · 10-Q 0000813672-24-000192 filed Oct 30, 2024Research and development · Q4 2024: $392M · derived · 10-K 0000813672-26-000016 filed Feb 19, 2026Research and development · Q1 2025: $439M · 10-Q 0000813672-25-000051 filed Apr 30, 2025Research and development · Q2 2025: $442M · 10-Q 0000813672-25-000113 filed Jul 30, 2025Research and development · Q3 2025: $423M · 10-Q 0000813672-25-000148 filed Oct 29, 2025Research and development · Q4 2025: $465M · derived · 10-K 0000813672-26-000016 filed Feb 19, 2026Research and development · Q1 2026: $508M · 10-Q 0000813672-26-000047 filed May 1, 2026370508180Q1 2016Q1 2026Q3 2023
$MResearch and development · Q3 2022: $324M · 10-Q 0000813672-22-000054 filed Oct 24, 2022Research and development · Q4 2022: $350M · derived · 10-K 0000813672-24-000034 filed Feb 14, 2024Research and development · Q1 2023: $350M · 10-Q 0000813672-23-000025 filed Apr 24, 2023Research and development · Q2 2023: $354M · 10-Q 0000813672-23-000041 filed Jul 24, 2023Research and development · Q3 2023: $370M · 10-Q 0000813672-23-000068 filed Oct 23, 2023Research and development · Q4 2023: $367M · derived · 10-K 0000813672-25-000024 filed Feb 21, 2025Research and development · Q1 2024: $379M · 10-Q 0000813672-24-000092 filed Apr 24, 2024Research and development · Q2 2024: $371M · 10-Q 0000813672-24-000155 filed Jul 24, 2024370371324379Q3 2022Q2 2024Q3 2023
Q3 2023
370$M
All values (41)
PeriodValue ($M)Status
Q1 2026508reported
Q4 2025465derived
Q3 2025423reported
Q2 2025442reported
Q1 2025439reported
Q4 2024392derived
Q3 2024407reported
Q2 2024371reported
Q1 2024379reported
Q4 2023367derived
Q3 2023370reported
Q2 2023354reported
Q1 2023350reported
Q4 2022350derived
Q3 2022324reported
Q2 2022287reported
Q1 2022291reported
Q4 2021289derived
Q3 2021289reported
Q2 2021285reported
Q1 2021271reported
Q4 2020290derived
Q3 2020251reported
Q2 2020251reported
Q1 2020242reported
Q4 2019235derived
Q3 2019241reported
Q2 2019232reported
Q1 2019228reported
Q4 2018218derived
Q3 2018223reported
Q2 2018219reported
Q1 2018224reported
Q4 2017203derived
Q3 2017207reported
Q2 2017196reported
Q1 2017198reported
Q4 2016182derived
Q3 2016192reported
Q2 2016182reported
Q1 2016180reported

CSV with all sources · Technical ID: rnd

More metrics for Cadence

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$370M
Period
Q3 2023, ended Sep 30, 2023 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Oct 23, 2023 · 0000813672-23-000068
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$370MOct 23, 202310-Q 0000813672-23-000068reported · confidence 1. · current